Clinical Trials Directory

Trials / Conditions / Metastatic Breast Cancer (MBC)

Metastatic Breast Cancer (MBC)

7 registered clinical trials studyying Metastatic Breast Cancer (MBC) — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients
NCT06833853
Menarini Silicon Biosystems, INC—
RecruitingEfficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cance
NCT06143553
Shanghai Yizhong Pharmaceutical Co., Ltd.Phase 3
Active Not RecruitingPalbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)
NCT02605486
Memorial Sloan Kettering Cancer CenterPhase 1 / Phase 2
CompletedPhase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer
NCT02312622
Joel NealPhase 2
CompletedA Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to
NCT01471847
Novartis PharmaceuticalsPhase 1
TerminatedPhase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Bre
NCT01495247
Novartis PharmaceuticalsPhase 1 / Phase 2
CompletedPhase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxan
NCT00236899
Eli Lilly and CompanyPhase 3